PictureTel names Bond as new chief executive

Article

PictureTel names Bond as new chief executiveVideoconferencing developer PictureTel has tapped Bruce Bond as president and CEO, effective March 1. Bond replaces Dr. Norman Gaut, who will continue to serve as chairman. Bond previously was CEO at

PictureTel names Bond as new chief executive

Videoconferencing developer PictureTel has tapped Bruce Bond as president and CEO, effective March 1. Bond replaces Dr. Norman Gaut, who will continue to serve as chairman. Bond previously was CEO at ANS, America Online's networking subsidiary that was recently sold to WorldCom.

In other PictureTel news, the Andover, MA-based firm has signed a joint development and marketing agreement with networking firm Fore Systems to develop standards-based LAN videoconferencing over ATM networks. Under the terms of the deal, Fore will develop ATM interfaces for PictureTel's family of LAN-based, H.323 videoconferencing client and server products. The addition of ATM network interfaces to the product family will enhance the quality, reliability, and performance of LAN-based videoconferencing over ATM networks, according to the firm.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.